In Hiroshima, the city devastated by the first nuclear bomb, the biopic's Academy Awards success met a mixed reaction
With pharmaceutical sales in the UAE set to reach US$3.8 billion by 2021, the brand is a growing business ready to meet the region's dynamic requirements. Which is why they are currently looking at expansion to Saudi Arabia, Yemen, Iraq and several other MENA markets.
Madhukar Tanna, CEO at Pharmax said: "At Pharmax, quality is a corporate culture built into every level of our organisation. We take our responsibility seriously and apply the same standards to our partner companies as to our own employees. We invest significant time and resources in training, to ensure that the highest quality is maintained right across our value chain. Our ultimate goal is to deliver products that will improve the lives of patients.
"Our production capacity has been mapped to cater to the demands of our own branded products and provide additional contract manufacturing services. Aurobindo Labs and Cipla from India, and MS Pharma from Jordan, are our current partners and more will be added soon."
Today, Pharmax is able to produce over 300 million tablets and capsules in its Dubai facility, backed by the latest Quality Management Systems certification, and FDA 21 CFR Part 11 software. In 2019, the company also received European Union Good Manufacturing Practice certification, which opens many opportunities in new markets, not only in the region but also in the EU.
The UAE Ministry of Health and Prevention (MoHAP) also recently approved Pharmax as the UAE's first laboratory for batch release of respiratory products, such as inhalers and nasal sprays. This will add significant value to its existing product portfolio.
Pharmax has also invested in the capability to release injectable formulations, to meet the demands for these types of medicine in the UAE. With the current Covid-19 health situation, the demand for generic medicine is likely to increase significantly and turning to local production will be key to fulfilling demand.
"As MoHAP celebrates 50 years, it has created one of the best healthcare standards in the region. The advent of universal health insurance has created significant change when it comes to accessing affordable, high-quality products. Private and public hospitals and community healthcare providers now depend on our products to ensure their patients receive their treatments on time, and to maintain their overall cost structure. As we look at the future, our mission at Pharmax will continue to be to support MoHAP, by producing affordable products at the highest quality standards, to help match the region's rising demands," Tanna stated.
In Hiroshima, the city devastated by the first nuclear bomb, the biopic's Academy Awards success met a mixed reaction
The Bollywood actor hosted the inaugural Hope Gala in London attended by prominent global personalities
More than 50 people are coming in to get the shot every day, doctors say
The nol cards can be used not only for public transport but also to make essential purchases at participating retail outlets in the emirate
The Italian company stands as the first Italian real estate brokerage group operating in the UAE
'The Australian batter also thinks 'there's no one better in India to have behind the stumps'
Policybazaar.ae unveils heartfelt short film advocating the need for term insurance
The app allows citizens to use digital documents on their smartphones instead of physical ones for identification and sharing purposes